How mRNA technology could revolutionise therapeutics

In this episode, we explore how mRNA technology could revolutionise cancer therapeutics.

In this podcast episode, titled ‘How mRNA could revolutionise therapeutics’, we will be discussing how mRNA vaccines for cancer treatment engage with the immune system to illicit an anti-tumour response, how they could synergise with other cancer treatments, as well as which cancers show most promise for this approach.

This conversation features Dr Rebecca Boohaker, Director of Oncology at Southern Research, and Fusataka Koide, Senior Director of Business Development at Southern Research.

Key discussion points:

• The specific challenges researchers face in utilising mRNA technology for cancer treatment
• How mRNA vaccines for cancer differ from conventional cancer treatments, and the advantages they offer
• The strategies being explored to enhance the delivery and stability of mRNA vaccines tailored for cancer immunotherapy
• The current advancements in mRNA vaccine development

This podcast is in association with Molecular Devices. With its innovative life science technology, Molecular Devices makes scientific breakthroughs possible for academic, pharmaceutical, government and biotech customers. Head to moleculardevices.com to find out more.